Drug Trial Radar · NCT02448797
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
Last checked: Nov 19, 2026Latest source record: Jul 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
320
Planned (sponsor's estimate)
Start
Jun 8, 2015
Primary completion
Jun 30, 2022
Study completion Dec 2023
Sponsor
- Lead sponsor
- Betta Pharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 19, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Adjuvant therapy has been proved effective in treating earlier stage or less advanced non-small-cell lung cancer. This study is designed to evaluate the efficacy of icotinib as adjuvant therapy in treating stage II-IIIA non-small cell lung cancer patients with EGFR mutation. The primary endpoint is disease-free survival.
Conditions
- Non-small Cell Lung Cancer
Interventions
IcotinibDrug
125 mg three times daily (375 mg per day) orally for two years.
ChemotherapyDrug
Vinorelbine 25 mg/m\^2, intravenously guttae, day 1 and day 8, 21 days/cycle, 4 cycles, cisplatin 75 mg/m\^2, intravenously guttae, day 1, 21 days/cycle, 4 cycles. For adenocarcinoma: pemetrexed (500 mg/m\^2, day 1)/cisplatin (75 mg/m\^2, day 1) for 4 cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- disease free survivalTime frame: 48 months
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
307 Hospital of PLA
Beijing, Beijing Municipality, China
Fujian Provincal Cancer Hospital
Fuzhou, Fujian, China
The First Affiliated Hospital Of Guangzhou Medical Collage
Guangzhou, Guangdong, China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
The First Hospital of China Medical University
Shenyang, Liaoning, China
First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
The First Affiliated Hospital of Medical School of Zhejiang University
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.